{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:40:22Z","timestamp":1787312422701,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.ijcard.2008.03.007","type":"journal-article","created":{"date-parts":[[2008,6,25]],"date-time":"2008-06-25T05:36:00Z","timestamp":1214372160000},"page":"367-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Onset and progression of the Anderson\u2013Fabry disease related cardiomyopathy"],"prefix":"10.1016","volume":"130","author":[{"given":"Christoph","family":"Kampmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ales","family":"Linhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Baehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Palecek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane M.","family":"Wiethoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Miebach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina","family":"Whybra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Gal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bultas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2008.03.007_bib1","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.167.3922.1268","article-title":"Fabry's disease: alpha-galactosidase deficiency","volume":"167","author":"Kint","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.ijcard.2008.03.007_bib2","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry's disease: ceramidetrihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2008.03.007_bib3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00431-003-1299-3","article-title":"The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents","volume":"162","author":"Ries","year":"2003","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.ijcard.2008.03.007_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","article-title":"Natural history of Fabry renal disease: influence of a-galactosidase A activity and genetic mutations on clinical course","volume":"81","author":"Branton","year":"2002","journal-title":"Medicine"},{"key":"10.1016\/j.ijcard.2008.03.007_bib5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0002-9149(69)90055-1","article-title":"The heart in Fabry's disease. A histochemical and electron microscopic study","volume":"24","author":"Ferrans","year":"1969","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2008.03.007_bib6","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00059-002-2429-9","article-title":"Fabry disease: focus on cardiac manifestations and molecular mechanisms","volume":"27","author":"Perrot","year":"2002","journal-title":"Herz"},{"key":"10.1016\/j.ijcard.2008.03.007_bib7","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s00392-002-0848-5","article-title":"The heart in Anderson Fabry disease","volume":"91","author":"Kampmann","year":"2002","journal-title":"Z Kardiol"},{"key":"10.1016\/j.ijcard.2008.03.007_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1651-2227.2002.tb03105.x","article-title":"Electrocardiographic signs of hypertrophy in Fabry disease-associated hypertrophic cardiomyopathy","volume":"91","author":"Kampmann","year":"2002","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.ijcard.2008.03.007_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1651-2227.2005.tb02103.x","article-title":"Fabry disease and the heart: an overview of the natural history and the effect of enzyme replacement therapy","volume":"94","author":"Shah","year":"2005","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.ijcard.2008.03.007_bib10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.amjcard.2005.05.033","article-title":"Prevalence and clinical significance of cardiac arrhythmia in Anderson\u2013Fabry disease","volume":"96","author":"Shah","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2008.03.007_bib11","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/hc3801.096352","article-title":"Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease. Reversal by enzyme replacement therapy","volume":"104","author":"Moore","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2008.03.007_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2261-2-1","article-title":"Arterial wall properties and womersley flow in Fabry disease","volume":"2","author":"Moore","year":"2002","journal-title":"BMC Cardiovasc Dis"},{"key":"10.1016\/j.ijcard.2008.03.007_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1161\/hs0202.102601","article-title":"Elevated cerebral blood flow velocities in Fabry disease with reversal after enzyme replacement","volume":"33","author":"Moore","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.ijcard.2008.03.007_bib14","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1012993305223","article-title":"Anderson\u2013Fabry disease: clinical manifestations of disease in female heterozygotes","volume":"24","author":"Whybra","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ijcard.2008.03.007_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/GIM.0b013e31802d8321","article-title":"Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life","volume":"9","author":"Wang","year":"2007","journal-title":"Genet Med"},{"key":"10.1016\/j.ijcard.2008.03.007_bib16","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson\u2013Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.ijcard.2008.03.007_bib17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson\u2013Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"MacDermot","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/j.ijcard.2008.03.007_bib18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jmg.2005.036327","article-title":"Natural history of Fabry disease in females in the Fabry outcome survey","volume":"43","author":"Deegan","year":"2006","journal-title":"J Med Genet"},{"key":"10.1016\/j.ijcard.2008.03.007_bib19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00392-005-0284-4","article-title":"Morbus Fabry of the heart. Why should cardiologists care?","volume":"94","author":"Strotmann","year":"2005","journal-title":"Z Kardiol"},{"key":"10.1016\/j.ijcard.2008.03.007_bib20","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1097\/01.ASN.0000015238.98011.AF","article-title":"Cardiac involvement in Anderson\u2013Fabry disease","volume":"13","author":"Kampmann","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ijcard.2008.03.007_bib21","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/eurheartj\/ehi143","article-title":"The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease","volume":"26","author":"Weidemann","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2008.03.007_bib22","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/hrt.2004.035584","article-title":"The natural history of left ventricular systolic function in Anderson\u2013Fabry disease","volume":"91","author":"Shah","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2008.03.007_bib23","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0735-1097(02)02380-X","article-title":"Cardiac manifestations of Anderson\u2013Fabry disease in heterozygous females","volume":"40","author":"Kampmann","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijcard.2008.03.007_bib24","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2008.03.007_bib25","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.CIR.58.6.1072","article-title":"Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements","volume":"58","author":"Sahn","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2008.03.007_bib26","doi-asserted-by":"crossref","first-page":"175S","DOI":"10.1093\/ajh\/5.6.175S","article-title":"Left ventricular mass as a measure of preclinical hypertensive disease","volume":"5","author":"Devereux","year":"1992","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ijcard.2008.03.007_bib27","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1067\/mhj.2000.105105","article-title":"New insights in cardiac structural changes in patients with Fabry's disease","volume":"139","author":"Linhart","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2008.03.007_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0002-9149(76)90491-4","article-title":"Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy","volume":"37","author":"Teichholz","year":"1976","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijcard.2008.03.007_bib29","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.CIR.64.6.1227","article-title":"Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale","volume":"64","author":"Goldman","year":"1981","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2008.03.007_bib30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF00296520","article-title":"A histochemical and electron microscopic study of skeletal and cardiac muscle from a Fabry disease patient and carrier","volume":"90","author":"Uchino","year":"1995","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1016\/j.ijcard.2008.03.007_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000014969","article-title":"X-chromosome inactivation: a repeat hypothesis","volume":"80","author":"Lyon","year":"1998","journal-title":"Cytogenet Cell Genet"},{"key":"10.1016\/j.ijcard.2008.03.007_bib32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/190372a0","article-title":"Gene action in the X-chromosome of the mouse (Mus musculus L.)","volume":"190","author":"Lyon","year":"1961","journal-title":"Nature"},{"issue":"suppl 447","key":"10.1016\/j.ijcard.2008.03.007_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/08035320510028049","article-title":"The right ventricle in Fabry disease","volume":"94","author":"Kampmann","year":"2005","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.ijcard.2008.03.007_bib34","first-page":"81","article-title":"Cardiac transplantation for Fabry's disease","volume":"14","author":"Cantor","year":"1998","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.ijcard.2008.03.007_bib35","first-page":"1978","article-title":"Atypical phenotype of Fabry disease. Evidence of a new mutation","volume":"29","author":"Derouiche","year":"2000","journal-title":"Presse Med"},{"key":"10.1016\/j.ijcard.2008.03.007_bib36","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0002-8703(95)90062-4","article-title":"Inherited restrictive cardiomyopathy in a 74-year-old woman: a case of Fabry's disease","volume":"129","author":"Hillsley","year":"1995","journal-title":"Am Heart J"},{"key":"10.1016\/j.ijcard.2008.03.007_bib37","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1253\/jcj.63.572","article-title":"Biopsy-proven cardiomyopathy in heterozygous Fabry's disease","volume":"63s","author":"Koitabashi","year":"1999","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.ijcard.2008.03.007_bib38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0167-5273(85)90179-2","article-title":"Progressive cardiac involvement by Fabry's disease despite successful renal allotransplantation","volume":"7","author":"Kramer","year":"1985","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcard.2008.03.007_bib39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1136\/hrt.57.3.296","article-title":"A case of heterozygous Fabry's disease with a short PR interval and giant negative T waves","volume":"57","author":"Yokoyama","year":"1987","journal-title":"Br Heart J"},{"key":"10.1016\/j.ijcard.2008.03.007_bib40","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1536\/jhj.45.685","article-title":"Fabry disease female proband with clinical manifestations similar to hypertrophic cardiomyopathy","volume":"45","author":"Teragaki","year":"2004","journal-title":"Jpn Heart J"},{"key":"10.1016\/j.ijcard.2008.03.007_bib41","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2169\/internalmedicine.38.476","article-title":"Fifteen-year follow-up of a heterozygous Fabry's disease patient associated with pre-excitation syndrome","volume":"38","author":"Murata","year":"1999","journal-title":"Intern Med"},{"key":"10.1016\/j.ijcard.2008.03.007_bib42","doi-asserted-by":"crossref","first-page":"528S","DOI":"10.1136\/hrt.2005.063818","article-title":"The heart in Anderson\u2013Fabry disease and other lysosomal storage disorders","volume":"93","author":"Linhart","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2008.03.007_bib43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1651-2227.2002.tb03106.x","article-title":"Isolated cardiac manifestations in Fabry disease: the UK experience","volume":"91","author":"Sachdev","year":"2002","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.ijcard.2008.03.007_bib44","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1007\/s00392-003-1018-0","article-title":"Is left ventricular hypertrabeculation\/noncompaction a cardiac manifestation of Fabry's disease?","volume":"92","author":"St\u00f6llberger","year":"2003","journal-title":"Z Kardiol"},{"key":"10.1016\/j.ijcard.2008.03.007_bib45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJM199102073240607","article-title":"An atypical variant of Fabry's disease with manifestations confined to the myocardium","volume":"324","author":"von Scheidt","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2008.03.007_bib46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human a-galactosidase A replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2008.03.007_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1086\/422366","article-title":"Long-term safety and efficacy of enzyme replacement therapy for Fabry disease","volume":"75","author":"Wilcox","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ijcard.2008.03.007_bib48","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease: a randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2008.03.007_bib49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfi152","article-title":"Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting","volume":"21","author":"Schiffmann","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ijcard.2008.03.007_bib50","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1681\/ASN.2006080816","article-title":"Sustained, long-term renal stabilization after 54\u00a0months of agalsidase Beta therapy in patients with Fabry disease","volume":"18","author":"Germain","year":"2007","journal-title":"J Am Soc Nepthology"},{"key":"10.1016\/j.ijcard.2008.03.007_bib51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","article-title":"Agalsidase-beta therapy for advanced Fabry disease: a randomized trial","volume":"146","author":"Banikazemi","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijcard.2008.03.007_bib52","first-page":"39","article-title":"Enzyme replacement therapy in Anderson\u2013Fabry cardiomyopathy","volume":"18","author":"Kampmann","year":"2002","journal-title":"Heart Metab"},{"key":"10.1016\/j.ijcard.2008.03.007_bib53","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1399-0004.2004.00284.x","article-title":"Enzyme replacement therapy with agalsidase b improves cardiac involvement in Fabry's disease","volume":"66","author":"Spinelli","year":"2004","journal-title":"Clin Genet"},{"key":"10.1016\/j.ijcard.2008.03.007_bib54","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.CIR.0000091253.71282.04","article-title":"Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease: a prospective strain rate imaging study","volume":"108","author":"Weidemann","year":"2003","journal-title":"Circulation"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527308004671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527308004671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:22:37Z","timestamp":1759090957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527308004671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0167527308004671"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2008.03.007","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Onset and progression of the Anderson\u2013Fabry disease related cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2008.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}